MOPEAD newsletter 01

The University of Cologne (Germany) is the second site to have started its patient recruitment for the MOPEAD project.

Recruitment has started with the pre-screening of 34 patients using the ‘Open House’ strategy. Seven of them have been referred for a form...

Fundacio ACE is the first site to start patient recruitment for the MOPEAD (Models Of Patient Engagement for Alzheimer’s Disease) project. Recruitment has started for the ‘Open House’ and ‘Tertiary care-based patient engagement’ strategies with 12 and 23 p...

The MOPEAD communication team has published an infographic illustrating risk factors that are associated with Alzheimer's disease. The infographic aims to raise awareness of these risk factors, particularly factors which are potentially modifiable, such as...

The MOPEAD communication team has published an infographic illustrating cognitive changes that may occur as a result of normal ageing compared with those that may be associated with dementia. The aim of this infographic is to raise awareness of these impor...

The communication team of the MOPEAD project has released an educational leaflet on Alzheimer's disease and other forms of dementia. The leaflet gives an insight on Alzheimer’s disease and commonly used terminology, risk factors and prevention. It describe...

The MOPEAD project was presented at Alzheimer Europe’s European Parliament lunch debate focussing on improving the diagnosis of Alzheimer’s disease thanks to European research collaboration.

MOPEAD illustrates how it can support earlier diagnosis of Alzheimer’s disease and dementia at Alzheimer Europe's third Alzheimer’s Association Academy .

MOPEAD communication team  has released an infographic on the ‘Value of Early Diagnosis’. The MOPEAD project is designed to assess different patient engagement models across Europe, to identify efficient approaches of earlier identification of mild Alzheim...

Learn about the project and hear from the MOPEAD collaborators in exclusive interviews.

See the full newsletter here.

The MOPEAD Consortium met in Berlin on 04/05 October 2017 after the Alzheimer Europe annual conference. The Consortium also invited a pool of external Advisors who enriched the MOPEAD implementation plan with their insight.

Please reload

Please reload

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations